Research Highlights

Research led by Fraser J. Sim, PhD, Associate Professor from the Department of Pharmacology and Toxicology, that seeks to spur development of cellular and molecular therapies for adult demyelinating disease, such as multiple sclerosis, has gained funding from the National Institutes of Health.

Sriram Neelamegham, PhD, Professor from the Department of Chemical and Biological Engineering, received grants to fund research focused on developing a systems level understanding of cellular glycosylation processes, using a combination of mathematical modeling methods and experiments.

Jian Feng, PhD, UB Distinguished Professor and researchers from the Department of Physiology and Biophysics  are studying genetic and epigenetic factors in Alzheimer’s disease to develop novel ways of restoring function to patients in the later stages of the neurodegenerative disorder.

Research led by Stelios Andreadis, PhD, SUNY Distinguished Professor from the Department of Chemical and Biological Engineering,  yields neural crest cells from adult skin cells, and could lead to new treatments for Parkinson’s and other brain illnesses.

A team of researchers led by Jonathan F. Lovell, PhD, Assistant Professor of the Department of Biomedical Engineering, has developed a new technique to make injectable medicine safer.

Richard Gronostajski, PhD, Professor of the Genetics, Genomics and Bioinformatics Program has been awarded a three-year, $1 million grant to study neural stem cell (NSCs) therapies for a variety of brain insults and injuries.

John M. Canty, MD — an attending cardiologist at the Buffalo VA Medical Center, SUNY Distinguished Professor and Albert and Elizabeth Rekate Professor of Medicine — has been awarded a $650,000 merit review grant from the Veterans Health Administration to explore why people die from ventricular fibrillation (VF) as the only manifestation of heart disease.